KTTA

PASITHEA THERAPEUTICS CORP.

KTTA · CIK 1841330 · Annual (10-K) · Last 4 years

Financial Trends

Revenue
20212024
Net Income−$14M
20212024
Operating CF
20212024
Free Cash Flow
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue——$0.0B$0.0B
Cost of Revenue——$0.0B$0.0B
Gross Profit———$-0.0B
R&D Expense$0.0B$0.0B$0.0B—
SG&A Expense$0.0B$0.0B$0.0B$0.0B
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-0.42$-0.42$-0.55$-0.21
EPS (Diluted)$-0.42$-0.42$-0.53—

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.0B$0.0B$0.0B$0.1B
Current Assets$0.0B$0.0B$0.0B$0.1B
Cash & Equivalents$0.0B$0.0B$0.0B$0.1B
Total Liabilities$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$0.0B$0.1B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow——$-0.0B$-0.0B
Investing Cash Flow——$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow——$-0.0B$0.1B
← Companies